NEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousandsNEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousands

Medome Launch Heralds the End of Medical Misdiagnoses and Lost Lives

2025/12/20 02:45
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

NEW YORK, Dec. 19, 2025 /PRNewswire/ — Medome is the first AI technology for Personal Health Records for consumers. Patented and clinically validated with thousands of real patients, it represents a groundbreaking approach to medical diagnostics, officially launching today to prevent misdiagnoses and improve patient outcomes. Created by physicians and technologists who have personally experienced the consequences of medical errors, Medome leverages advanced AI to bridge the gap between patients and the accurate healthcare they crave.

Medome arose from a tragic loss. Dr. Steven Charlap, a physician and entrepreneur, lost his brother to a preventable cancer medical diagnosis error. These preventable events underscore a devastating reality: nearly 400,000 people in the U.S. die each year due to errors in the diagnostic processes.

Driven by these experiences, the Medome team has harnessed the potential of AI to change the course of patient safety. “Medome exists so no one else dies again from misdiagnosis,” Dr. Charlap says, emphasizing that this platform was built to save lives through superior medical diagnostics.

Medome is not just another patient-facing symptom checker or a basic ai doctor; it is a comprehensive ai doctor diagnosis system. By utilizing sophisticated AI systems to organize, synthesize, and analyze personal information from lab results to family history Medome portrays a complete picture, uncovering patterns that often get missed.

Unlike other tools, Medome performs multiple intense calibrations in real time to narrow down possibilities. Dr. Charlap explains, “Medical knowledge now exceeds human intellectual capabilities. Our goal is not to replace human doctors but to enable patients to assist clinicians by being more contributory to their health journeys.” By using artificial intelligence as the bridge, the platform enhances decisions and identifies safety issues early when they are most effectively treated.

Medome represents a paradigm shift where enabled patients work alongside their providers. By applying proprietary methodologies to complex data, Medome which received support from Stanford, Harvard, the NIH, and the UK’s National Health Services enables patients to exert greater control over their diagnosis and treatment plan.

“We built Medome to save lives and ensure no one has to encounter a physician alone again,” Dr. Charlap concludes.

About Medome

Medome is an ai medical diagnosis and health intelligence platform that consolidates your medical history to provide a personalized treatment plan and prevent crises. It analyzes symptoms against your unique risk profile and distinguishes a local emergency from manageable problems. When you do need urgent care, it instantly generates a comprehensive medical summary to optimize diagnostic processes. Think of it as a medical command center that knows you better than any 15-minute appointment ever could.

Users can learn more at: www.medome.ai

Contact
Medome
media@medome.ai

Photo – https://mma.prnewswire.com/media/2849829/Medome_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medome-launch-heralds-the-end-of-medical-misdiagnoses-and-lost-lives-302647184.html

SOURCE Medome

시장 기회
플러리싱 에이아이 로고
플러리싱 에이아이 가격(SLEEPLESSAI)
$0.02236
$0.02236$0.02236
+0.76%
USD
플러리싱 에이아이 (SLEEPLESSAI) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

Starter Gold Rush: Win $2,500!

Starter Gold Rush: Win $2,500!Starter Gold Rush: Win $2,500!

Start your first trade & capture every Alpha move